ATC(II) Collaboration [ 8 ] concluded that antiplatelet therapy (aspirin plus dipyridamole (A) or aspirin alone (B)) produced a highly significant (2p ≤ 0.00001) reduction in vascular occlusion in a wide range of patients.
1
—
—
ATC(II) Collaboration [ 8 ] concluded that antiplatelet therapy (aspirin plus dipyridamole (A) or aspirin alone (B)) produced a highly significant (2p ≤ 0.00001) reduction in vascular occlusion in a wide range of patients.